Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GAD1 |
| Upstream (Parents) |
|---|
| (<<) ASB1 → GAD1 |
| (<<) CLDN5 → GAD1 |
| (<<) GPX4 → GAD1 |
| (<<) HDAC4 → GAD1 |
| (<<) HSD17B2 → GAD1 |
| (<<) INSR → GAD1 |
| (<<) ITGA6 → GAD1 |
| (<<) ITGB5 → GAD1 |
| (<<) JHDM1D → GAD1 |
| (<<) MAP3K3 → GAD1 |
| (<<) NFIB → GAD1 |
| (<<) NRN1 → GAD1 |
| (<<) PCSK1N → GAD1 |
| (<<) PKIG → GAD1 |
| (<<) RDH16 → GAD1 |
| (<<) SEH1L → GAD1 |
| (<<) SLC6A14 → GAD1 |
| (<<) SPRY2 → GAD1 |
| (<<) STAT5A → GAD1 |
| (<<) TNF → GAD1 |
| (<<) WBP4 → GAD1 |
| Downstream (Children) |
|---|
| GAD1 → DLX2 (>>) |
| GAD1 → SOX3 (>>) |
